EP12.01. Exceptional Response to Aumolertinib in an Advanced NSCLC Patient With Rare EGFR Exon20 V774M and S768I Mutations - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Tao Tao
Meta Tag
Speaker Tao Tao
Topic Metastatic NSCLC: Targeted Therapy - EGFR/HER2
WCLC 2023 conference
case report
EGFR exon20 mutations
third-generation EGFR-TKI
tumor shrinkage
brain metastases
anti-angiogenic drug
treatment regimens
Powered By